49
Participants
Start Date
August 31, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
March 31, 2009
V10153
Single acute intravenous bolus dose up to 10 mg/kg
Lancaster General Hospital, Lancaster
University of Pennsylvania Medical Center, Philadelphia
Forsyth Medical Center, Winston-Salem
Stroke Centre, Neurological Institute, Carolinas Medical Centre, Charlotte
Medical University South Carolina Hospitals and Clinics, Charleston
Tallahassee Memorial Hospital, Tallahassee
Florida Hospital of Neuroscience Institute, Orlando
Bethesda Memorial Hospital, Boynton Beach
Florida Neurovascular Institue Stroke Center, Tampa
Bradenton Research Centre, Bradenton
Ocala Neurodiagnostic Centre, Ocala
Erlanger Health System, Chattanooga
Center for Advanced Medicine, Jewish Hospital, Louisville
University of Louisville Hospital, Louisville
Vascular Neurology, Loyola University Medical Center, Maywood
Neurological Institute, The Methodist Hospital, Houston
Stroke Centre, Mayo Clinic, Scottsdale
Sunrise Hospital and Medical Centre, Las Vegas
Washoe Stroke Center, Reno
UCLA Stroke Network, Los Angeles
Neurology Medical Group of Diablo Valley, Walnut Creek
UMAS Memorial Medical Centre, Worcester
Division of Neuro-Ophthalmology, Virginia Commonwealth University, Richmond
Gordon & Leslie Diamond Health Care Centre, Vancouver
Centre for Stroke Research, Vancouver Island Health Research Centre, Victoria
71 King Street West, Mississauga
Royal University Hospital, Saskatoon
Hospital Charles LeMoyne, Québec
Vernalis (R&D) Ltd
INDUSTRY